217 related articles for article (PubMed ID: 23819992)
21. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
[TBL] [Abstract][Full Text] [Related]
22. Autoantibody repertoire to Ro/SSA and La/SSB antigens in patients with primary and secondary Sjögren's syndrome.
Wahren M; Solomin L; Pettersson I; Isenberg D
J Autoimmun; 1996 Aug; 9(4):537-44. PubMed ID: 8864830
[TBL] [Abstract][Full Text] [Related]
23. [HLA antigens in patients with Sjögren's syndrome].
Moutsopoulos HM; Papasteriades CA; Skopouli FN; Drosos AA
Ter Arkh; 1988; 60(4):28-30. PubMed ID: 3260692
[TBL] [Abstract][Full Text] [Related]
24. Anti-Ro(SS-A) HLA-DR3-positive women: the interrelationship between some ANA negative, SS, SCLE, and NLE mothers and SS/LE overlap female patients.
Provost TT; Watson R
J Invest Dermatol; 1993 Jan; 100(1):14S-20S. PubMed ID: 8423383
[TBL] [Abstract][Full Text] [Related]
25. Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjögren's syndrome.
Aqrawi LA; Skarstein K; Øijordsbakken G; Brokstad KA
Clin Exp Immunol; 2013 May; 172(2):228-37. PubMed ID: 23574319
[TBL] [Abstract][Full Text] [Related]
26. A re-evaluation of anti-NA-14 antibodies in patients with primary Sjögren's syndrome: Significant role of interferon-γ in the production of autoantibodies against NA-14.
Uomori K; Nozawa K; Ikeda K; Doe K; Yamada Y; Yamaguchi A; Fujishiro M; Kawasaki M; Morimoto S; Takamori K; Sekigawa I; Chan EK; Takasaki Y
Autoimmunity; 2016 Aug; 49(5):347-56. PubMed ID: 27328271
[TBL] [Abstract][Full Text] [Related]
27. Ro(SS-A) positive Sjogren's/lupus erythematosus (SC/LE) overlap patients are associated with the HLA-DR3 and/or DRw6 phenotypes.
Provost TT; Talal N; Bias W; Harley JB; Reichlin M; Alexander EL
J Invest Dermatol; 1988 Oct; 91(4):369-71. PubMed ID: 3262691
[TBL] [Abstract][Full Text] [Related]
28. Potential contribution of interleukin-33 to the development of interstitial lung disease in patients with primary Sjogren's Syndrome.
Zhao L; Yao L; Yuan L; Xia L; Shen H; Lu J
Cytokine; 2013 Oct; 64(1):22-4. PubMed ID: 23910012
[TBL] [Abstract][Full Text] [Related]
29. Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.
Liu Y; Liao X; Wang Y; Chen S; Sun Y; Lin Q; Shi G
Oncotarget; 2017 Feb; 8(9):14306-14313. PubMed ID: 28147328
[TBL] [Abstract][Full Text] [Related]
30. TAP, HLA-DQB1, and HLA-DRB1 polymorphism in Colombian patients with primary Sjögren's syndrome.
Anaya JM; Correa PA; Mantilla RD; Arcos-Burgos M
Semin Arthritis Rheum; 2002 Jun; 31(6):396-405. PubMed ID: 12077712
[TBL] [Abstract][Full Text] [Related]
31. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
[TBL] [Abstract][Full Text] [Related]
32. Recombinant 52 kDa Ro(SSA) ELISA detects autoantibodies in Sjögren's syndrome sera that go undetected by conventional serologic assays.
McCauliffe DP; Wang L; Satoh M; Reeves WH; Small D
J Rheumatol; 1997 May; 24(5):860-6. PubMed ID: 9150073
[TBL] [Abstract][Full Text] [Related]
33. In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren's syndrome.
Volchenkov R; Brun JG; Jonsson R; Appel S
Arthritis Res Ther; 2013; 15(5):R114. PubMed ID: 24025795
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of interleukin-34 and clinical correlation in patients with primary Sjögren's syndrome.
Liu Y; Zhang B; Lei Y; Xia L; Lu J; Shen H
Int J Rheum Dis; 2020 Mar; 23(3):374-380. PubMed ID: 31823505
[TBL] [Abstract][Full Text] [Related]
35. Association of BAFF and IL-17A with subphenotypes of primary Sjögren's syndrome.
Deng F; Chen J; Zheng J; Chen Y; Huang R; Yin J; Gao X; Lin Q; Huang C; Gao Y; Yu X; Liu Z
Int J Rheum Dis; 2016 Jul; 19(7):715-20. PubMed ID: 25941062
[TBL] [Abstract][Full Text] [Related]
36. [Immunogenetics of the Sjogren's syndrome in southern Spain].
García Portales R; Belmonte Lope MA; Camps García MT; Ocón Sánchez P; Alonso Ortiz A; Guil García M; de Ramón Garrido E
An Med Interna; 1994 Feb; 11(2):56-61. PubMed ID: 8193233
[TBL] [Abstract][Full Text] [Related]
37. [Antibodies against recombinant Ro 60 Kd, Ro 52 and La 48 Kd proteins in primary Sjogren's Syndrome. Utility of analytic methods combination to detect antibodies anti Ro and La].
Aguilera S; González MJ; Pérez P; Castillo D; Gatica H
Rev Med Chil; 2002 Aug; 130(8):841-9. PubMed ID: 12360791
[TBL] [Abstract][Full Text] [Related]
38. Elevated IL-37, IL-18 and IL-18BP serum concentrations in patients with primary Sjögren's syndrome.
Liuqing W; Liping X; Hui S; Jing L
J Investig Med; 2017 Mar; 65(3):717-721. PubMed ID: 28057714
[TBL] [Abstract][Full Text] [Related]
39. HLA-alloantigen associations in Greek patients with Sjögren's syndrome.
Papasteriades CA; Skopouli FN; Drosos AA; Andonopoulos AP; Moutsopoulos HM
J Autoimmun; 1988 Feb; 1(1):85-90. PubMed ID: 3151145
[TBL] [Abstract][Full Text] [Related]
40. Candidate T cell epitopes of the human La/SSB autoantigen.
Davies ML; Taylor EJ; Gordon C; Young SP; Welsh K; Bunce M; Wordsworth BP; Davidson B; Bowman SJ
Arthritis Rheum; 2002 Jan; 46(1):209-14. PubMed ID: 11817592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
